Kim Dae Hwan, Lee So Min, Lee Yun Jung, Yoon Jung Joo, Tan Rui, Yu Yun Cho, Kang Dae Gill, Lee Ho Sub
College of Oriental Medicine and Professional Graduate School of Oriental Medicine, Wonkwang University, Iksan, Jeonbuk, 54538, Republic of Korea.
Hanbang Body-fluid Research Center, Wonkwang University, Iksan, Jeonbuk, 54538, Republic of Korea.
Chin J Integr Med. 2017 Jan 24. doi: 10.1007/s11655-017-2759-3.
To investigate whether Paeotang (10-50 μg/mL) suppresses tumor necrosis factor α (TNF-α)-induced vascular inflammatory processes in human umbilical vein endothelial cells (HUVEC).
The ingredients composed of Paeotang include Glycyrrhiza glabra, Zingiber officinale, Cinnamomum zeylanuicum, Salvia miltiorrhiza, Prunus persica, Paeonia szechuanica, Poria cocos and Cynanchum wilfordii. Herbs were mixed according to equal ratio of weight and ground into a crude powder. The effect of Paeotang on the expression of cell adhesion molecules and protective role in HUVEC stimulated by TNF-α were evaluated.
Pretreatment with Paeotang decreased TNF-α-induced adhesion of HL-60 monocytic cells, as well as protein and mRNA expressions of intracellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1) and endothelial-selectin (E-selectin). Paeotang also dose-dependently inhibited TNF-α-induced matrix metalloproteinase-2 and -9 expressions. Paeotang significantly decreased TNF-α-induced intracellular reactive oxygen species (ROS) production. The Western blot and immunofluorescence analysis showed that Paeotang suppressed the translocation of p65 nuclear factor κB (NF-κB) to the nucleus. In addition, Paeotang inhibited the TNF-α-induced degradation of NF-κB inhibitor α (IκB-α) and by inhibiting the phosphorylation of IκB-α. Furthermore, pretreatment of Paeotang increased the heme oxygenase 1 (HO-1) and nuclear factor erythroid-2-related factor 2 (Nrf2) protein expression in HUVECs stimulated TNF-α. HO-1 was inhibited by Sn-protoporphyrin, HO-1 inhibitor, and increased by cobalt protopophyrin, HO-1 inducer. Furthermore, HO-1 induction was increased by single processing of Paeotang in a dose-dependent manner.
These data suggest that Paeotang might be a benefificial therapeutic in vascular inflflammation through regulation of Nrf2-mediated HO-1 expression and inhibition of ROS/NF-κB signaling pathway. Thus, Paeotang maybe serve as a potential anti-atherogenic agent.
研究芍药汤(10 - 50μg/mL)是否能抑制肿瘤坏死因子α(TNF-α)诱导的人脐静脉内皮细胞(HUVEC)中的血管炎症过程。
芍药汤的成分包括光果甘草、生姜、锡兰肉桂、丹参、桃仁、四川芍药、茯苓和白薇。将这些草药按等重量比例混合并研磨成粗粉。评估芍药汤对细胞黏附分子表达的影响以及对TNF-α刺激的HUVEC的保护作用。
芍药汤预处理可降低TNF-α诱导的HL-60单核细胞黏附,以及细胞间黏附分子1(ICAM-1)、血管细胞黏附分子1(VCAM-1)和内皮细胞选择素(E-selectin)的蛋白质和mRNA表达。芍药汤还呈剂量依赖性抑制TNF-α诱导的基质金属蛋白酶-2和-9表达。芍药汤显著降低TNF-α诱导的细胞内活性氧(ROS)产生。蛋白质免疫印迹和免疫荧光分析表明,芍药汤可抑制p65核因子κB(NF-κB)向细胞核的转位。此外,芍药汤通过抑制IκB-α的磷酸化,抑制TNF-α诱导的NF-κB抑制因子α(IκB-α)降解。此外,芍药汤预处理可增加TNF-α刺激的HUVEC中血红素加氧酶1(HO-1)和核因子红细胞2相关因子2(Nrf2)蛋白表达。HO-1被HO-1抑制剂锡原卟啉抑制,被HO-1诱导剂钴原卟啉增加。此外,芍药汤单次处理以剂量依赖性方式增加HO-1诱导。
这些数据表明,芍药汤可能通过调节Nrf2介导的HO-1表达和抑制ROS/NF-κB信号通路,对血管炎症具有有益的治疗作用。因此,芍药汤可能是一种潜在的抗动脉粥样硬化药物。